Steinbach, William J.
William J Steinbach researcher
VIAF ID: 75798417 (Personal)
Permalink: http://viaf.org/viaf/75798417
Preferred Forms
- 100 1 _ ‡a Steinbach, William J
- 100 1 _ ‡a Steinbach, William J.
-
- 100 1 _ ‡a Steinbach, William J.
- 100 1 _ ‡a Steinbach, William J.
-
-
-
-
- 100 1 _ ‡a Steinbach, William J.
-
- 100 0 _ ‡a William J Steinbach ‡c researcher
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data | |
Aspergillus fumigatus and aspergillosis, c2009: | |
Calcineurin as a Multifunctional Regulator: Unraveling Novel Functions in Fungal Stress Responses, Hyphal Growth, Drug Resistance, and Pathogenesis | |
Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus | |
Candida bloodstream infection in neonates | |
Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus | |
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. | |
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production | |
Empirical therapy for neonatal candidemia in very low birth weight infants | |
Feigin and Cherry's textbook of pediatric infectious diseases | |
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. | |
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections | |
Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis. | |
Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus. | |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients | |
A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients | |
Nelson's pediatric antimicrobial therapy | |
Newer antifungal therapy for emerging fungal pathogens | |
Pediatria Nelsona : leczenie zakażeń | |
Pediatric resident training in the diagnosis and treatment of acute otitis media | |
Phosphorylation of Calcineurin at a novel serine-proline rich region orchestrates hyphal growth and virulence in Aspergillus fumigatus | |
Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections | |
Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting | |
Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis | |
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium | |
Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review | |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide | |
Status of medical mycology education | |
Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs. | |
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America |